United Kingdom· GB-APID-23584211000001109
Bexsero vaccine suspension for injection 0.5ml pre-filled syringes
A medicinal product containing meningococcal group b vaccine, registered in United Kingdom by GlaxoSmithKline UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Meningococcal group B vaccine
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 6
- gtin5050459002921
- gtin5000123114641
- gtin05050459000682
- gtin5050459002877
- gtin05000123114658
- gtin5050459001412
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db061ed9-a6ec-4d01-b41d-e69b364e72fc GET /v1/drugs/db061ed9-a6ec-4d01-b41d-e69b364e72fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23584211000001109",
"desc": "Bexsero vaccine suspension for injection 0.5ml pre-filled syringes (GlaxoSmithKline UK Ltd)",
"form": "Suspension for injection",
"vpid": "23611911000001107",
"source": "dmd",
"vtm_id": "23612311000001102",
"strength": null,
"substance": "Meningococcal group B vaccine",
"ingredient": "Neisseria meningitidis group B NadA protein",
"supplier_code": "4012301000001105"
}See everything about meningococcal group b vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.